# Systemic Effects of Oral Antibiotics in Mice: A Combined Physiological and Molecular Approach

**Authors:** Ilir Mazreku, Aulon Kasolli, Zana Gerxhaliu, Melek Smaili, Avni Berisha, Savaş Kaya, Alejandro Morales-Bayuelo

PMC · DOI: 10.3390/biom16030409 · Biomolecules · 2026-03-10

## TL;DR

This study explores how amoxicillin and tetracycline affect mice's weight, food intake, and immune responses, finding that these effects may be due to microbiota disruption and immune signaling.

## Contribution

The study introduces a combined physiological and molecular approach to understand antibiotic effects, revealing sex-specific responses and potential immunomodulatory mechanisms.

## Key findings

- Both antibiotics reduced weight gain and food efficiency in mice with sex-specific effects.
- Tetracycline showed strong binding to TLR2, suggesting possible immunomodulatory action.
- Metabolic effects are likely due to microbiota disruption, not direct receptor engagement.

## Abstract

This study investigates the systemic effects of amoxicillin and tetracycline on healthy Mus musculus (Swiss albino) mice, focusing on food intake, body weight, and hematological parameters. Over a 14-day oral treatment period, both antibiotics significantly reduced weight gain and food efficiency, with sex-specific variations: tetracycline had stronger metabolic effects in males, while amoxicillin was more impactful in females. To explore underlying mechanisms, molecular docking and MM-GBSA analyses were performed on PPAR-γ and TLR2–TIRAP complexes. Both antibiotics showed negligible binding to PPAR-γ, suggesting their metabolic effects are not receptor-mediated. In contrast, tetracycline exhibited strong and stable binding to TLR2 (ΔGbind = −27.87 kcal/mol), supported by extensive hydrogen bonding, implying potential immunomodulatory action. These findings suggest that antibiotic-induced metabolic and immune alterations are more likely driven by microbiota disruption and innate immune signaling, rather than direct metabolic receptor engagement.

## Linked entities

- **Proteins:** PPARG (peroxisome proliferator activated receptor gamma), TLR2 (toll like receptor 2), TIRAP (TIR domain containing adaptor protein)
- **Chemicals:** amoxicillin (PubChem CID 33613), tetracycline (PubChem CID 54675776)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tirap (toll-interleukin 1 receptor (TIR) domain-containing adaptor protein) [NCBI Gene 117149] {aka C130027E04Rik, Mal, Tlr4ap, Wyatt}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}
- **Diseases:** weight gain (MESH:D015430)
- **Chemicals:** amoxicillin (MESH:D000658), hydrogen (MESH:D006859), tetracycline (MESH:D013752)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023510/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13023510/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023510/full.md

---
Source: https://tomesphere.com/paper/PMC13023510